Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dermatophagoides farinae is a standardized allergen extract derived from the house dust mite species Dermatophagoides farinae. It is used for both diagnostic testing and immunotherapy in patients with allergic rhinitis and/or conjunctivitis caused by sensitization to house dust mites. The mechanism of action involves repeated exposure to small amounts of the allergen, which helps desensitize the immune system and reduce allergic symptoms over time[5][7][8]. Immunotherapy can be administered via subcutaneous injection or sublingual tablets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dermatophagoides farinae.